Anit Roy, BS, is affiliated with Takeda Pharmaceuticals USA, Inc., Lexington, Massachusetts. Roy has published research on Attention-Deficit/Hyperactivity Disorder (ADHD) with a focus on both child and adolescent psychiatry as well as adult experiences during the COVID-19 pandemic. The work includes studies on caregiver and patient perspectives managing ADHD in the context of the pandemic. Roy's publications appear in Psychiatrist.com, collaborating frequently with co-authors Karen Klahn, Maggie McCue, Mary C. Burke, Michael Martin, and Sara Sarkey.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
